marketresearchtrends

Antibiotic Resistance Market Antimicrobial resistance occurs when microorganisms such as bacteria, viruses, fungi, and parasites change when they are exposed to antimicrobial drugs. Antibiotic drugs include antibiotics, antifungals, antivirals, antimalarials, and anthelmintic. Antibiotic resistance market is expected to reach USD 17.12 billion by 2030 at CAGR of 5.34% during the forecast period of 2023 to 2030 The growth of global antibiotic resistance market is driven by various factors such as -      Rising antibiotic drug resistance infections, rise in the incidence of chronic and infectious disease, increase in clinical developments of antibiotic resistance, and rise in global initiatives to control drug-resistance Several market players currently dominate the global antibiotic resistance market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. Major Key Players: Some of the Antibiotic Resistance Mar

Healthcare Cyber Security Market Healthcare cybersecurity has been growing at a rapid pace over the last few years. Cyberattacks in the healthcare industry is one of the primary factors causing a significant loss to the industry. In the last few years, hacking into information and information technology (IT) security breaches have risen at a steady rate, and many healthcare organizations have struggled to prevent their data from cybercrime. The Healthcare Cyber Security Market is expected to grow at CAGR of 17.3% to reach USD 55.61 Billion by 2030. Healthcare Cyber Security Growth Boosters The global healthcare cybersecurity market is estimated to put a strong foundation of propelling growth on the increasing need for network security, a type of IT security widely sought by healthcare organizations. Access control and distributed denial-of-service (DDoS) mitigation are some of the extremely sophisticated types of network security solutions that ensure esteem protection. In

Viscosupplementation Market The viscosupplementation market is anticipated to reach USD 4,760 Million by 2030 at 11.32% CAGR during the forecast period 2022-2030 Market Research Future (MRFR) discusses the market and considers the time frame as the forecast period. Viscosupplementation can be defined as a process that requires physicians to inject a lubricating fluid-like hyaluronic acid (HA) injection or hyaluronan injection into a joint as an attempt to treat symptoms various forms of osteoarthritis like knee, hip, shoulder, ankle, and spine arthritis. Increasing demand for minimally-invasive surgeries can make sure that the market gains a better growth rate and fetches good revenues. Among other features, initiatives taken by various investors, rising cases of obesity, diabetes, hypertension, renal failure, gastrointestinal bleeding, cardiovascular diseases, depression, disability in the geriatric population can trigger a hike in the growth rate of the viscosupplementation

Animal Vaccines Market Animal Vaccines Market registering a CAGR of 7.50% during the forecast period (2023 - 2030) and expected to reach USD 15.26 billion by 2030. The animal vaccines market suffered immensely because pet owners and farmers were encouraged to keep their animals at home. They were advised against taking their pets to the vet to get strong and effective vaccines like the Pfizer veterinary vaccines. Growth in the veterinary/animal vaccines market is starting to pick up dramatically now that a vaccine for COVID-19 is being widely administered. Demand for animal vaccines is surging because livestock on farms around the world need these to remain healthy. Major Key Players: Some of the Animal Vaccines Market Players are Boehringer Ingelheim International GmbH (Germany), Zoetis Inc. (US), Ceva Santé Animale (France), Merck & Co., Inc. (US), Elanco Animal Health Incorporated (US), Virbac (France), Phibro Animal Health Corporation (US), Hipra (Spain), Biogén

Oncology Information Systems Market Oncology Information Systems Market Size was valued at USD 2.8 billion in 2022 and is projected to grow from USD 3.01 Billion in 2023 to USD 4.6 billion by 2030, at CAGR 7.50% during forecast. Rising awareness about the utility of oncology information systems in making cancer treatments easier for both patients and doctors is likely to drive the global oncology information systems market over the forecast period. This is likely to remain the major driver for the global oncology information systems market over the forecast period, as the growing prevalence of cancer drives proportionate growth in the markets for other equipment and devices needed to treat it. The increasing investment in cancer research and technological upgrades in cancer treatment equipment is also likely to be a major driver for the global oncology information systems market over the forecast period. Technological advancements in oncology information systems could play

High Potency APIs Market High potency APIs facilitate precision and targeted therapy approach. Thus, the rising prevalence of chronic and old age diseases have intensified the demand for HPAPIs. The high potency APIs market will rake USD 47.77 billion in revenues while expanding with an 8.90% CAGR in the 2022-2030. The rapid expansion of cancer patient pool is forecasted to accelerate the revenue creation for the market players globally. According to ‘Our World in Data’, 8.9 million people are estimated to have succumbed to cancer in 2016. Investments are expected to flow towards drug development which is likely to augment the global market through the review period. The competitive landscape of the market is highly lucrative and rising investments is prognosticated to boost the manufacturing of HPAPIs. Furthermore, the key players are anticipated to strategize agreements, acquisitions, and partnerships for gaining edge over competitors. The developments witnessed in the healt

Menopause Treatment Market Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. Global Menopause Treatment Market  is expected to have a market value of  USD 15,456.3 Million by 2027.  For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry. Major Key Players: MRFR recognizes the following companies as the  M